Point-of-care testing: Fast, practical diagnostics for modern healthcare

Point-of-care testing (PoCT) is reshaping how clinicians diagnose, treat and monitor patients by delivering rapid results at or near the patient. In a world where timely decisions can alter outcomes, PoCT bridges the gap between laboratory accuracy and bedside practicality. This article explores what Point-of-care testing is, how it works, where it fits into contemporary care, and what this means for clinicians, patients and healthcare systems across the United Kingdom and beyond.

What is Point-of-care testing?

Point-of-care testing, also written as point-of-care testing in some contexts, refers to diagnostic testing performed at or near the site of patient care. The aim is to provide immediate results that inform clinical decisions during the same encounter. While conventional laboratory testing typically involves samples sent to a central lab with turnaround times measured in hours, PoCT seeks to deliver results in minutes, enabling faster triage, treatment initiation or risk stratification.

In practice, Point-of-care testing encompasses a range of technologies, from simple dipstick tests to advanced handheld analysers and microfluidic systems. The core principle is proximity: reducing the distance between testing and decision-making. Whether in a GP surgery, an emergency department, a rural clinic, or a patient’s home, PoCT can empower clinicians to act swiftly and appropriately, potentially improving outcomes and patient experience.

Origins and evolution of Point-of-care testing

The concept of testing at the point of care has roots in laboratory science from the early to mid-20th century, but modern PoCT evolved rapidly with advances in biosensing, microfluidics and portable electronics. Early PoCT devices relied on simple chemical reactions that produced visible results. Today’s Point-of-care testing devices can perform complex analyses, including immunoassays, coagulation testing and molecular diagnostics, with automation and connectivity that link results to patient records and decision-support tools.

Across healthcare systems, the adoption of Point-of-care testing has followed a similar arc: pilot studies in high-demand settings, rolled-out programmes in primary and urgent care, and increasingly integrated use in specialised services such as obstetrics, critical care and chronic disease management. The evolution continues as devices become smaller, more accurate and capable of multiplex testing—that is, detecting multiple targets from a single sample.

Why Point-of-care testing matters in modern healthcare

Point-of-care testing changes how clinicians conceptualise diagnosis and treatment. It supports rapid triage, reduces waiting times, and can narrow the gap between symptom onset and therapeutic action. In acute settings, a timely PoCT result can determine whether a patient is admitted, discharged or transferred, while in primary care, it can inform whether to prescribe, monitor or refer for further testing.

Speed and clinical decision making

One of the strongest advantages of Point-of-care testing is its speed. In emergency departments, a point-of-care haemoglobin or blood gas analysis may guide fluid management and transfusion decisions within the same patient encounter. In primary care, a rapid infectious disease test or glucose reading can shape management plans before the patient leaves the clinic. The speed of results supports evidence-based decisions and can reduce the risks associated with delayed treatment.

Patient-centred care and experience

For patients, PoCT can improve experience by providing immediate feedback, enabling shared decision making, and reducing the need for follow-up visits. When a clinician can discuss a test result and its implications on the spot, patients feel more engaged in their care and often have greater confidence in the management plan.

Resource optimisation and workflow efficiency

Point-of-care testing can optimise resource utilisation by diverting appropriate cases away from the central laboratory, freeing up capacity for high-complexity analyses. In busy clinics, PoCT can streamline triage workflows, shorten patient pathways and improve throughput, while still upholding quality and safety standards.

Key technologies underpinning Point-of-care testing

PoCT relies on a spectrum of technologies, from traditional lateral flow immunoassays to sophisticated electrochemical sensors and molecular diagnostics. The diversity of platforms enables testing across diverse clinical scenarios and settings.

Lateral flow and immunochromatographic assays

Lateral flow tests are among the most familiar Point-of-care devices. They are simple, rapid, and increasingly quantitative with enhanced readouts. Common examples include pregnancy tests, infectious disease panels and basic inflammatory marker screens. Advances in materials and detection methods have improved sensitivity and specificity, expanding the range of conditions that can be screened at the point of care.

Electrochemical and optical biosensors

Electrochemical sensors convert a biological interaction into an electrical signal, enabling precise quantification of biomarkers such as electrolytes, metabolites or cardiac markers. Optical sensors, including fluorescence and absorbance-based systems, provide robust readouts for a variety of targets. These technologies underpin many modern handheld devices used in clinics and home testing alike.

Molecular and nucleic acid testing at the point of care

Advances in rapid nucleic acid amplification and detection have given rise to Point-of-care molecular testing. Portable systems can identify pathogens with sensitivity comparable to laboratory assays, enabling rapid antimicrobial stewardship and targeted therapy in urgent care environments. While these devices are more complex, they are designed with user-friendly interfaces and built-in quality controls to support safe operation outside traditional laboratories.

Microfluidics and lab-on-a-chip

Microfluidic technologies enable precise handling of tiny volumes of fluids, enabling complex assays to be miniaturised onto chips. Lab-on-a-chip approaches support multiplex testing and integration with data management systems. The result is compact, low-consumption devices capable of delivering a broad panel of results at the point of care.

Connectivity, data management and decision support

Effective PoCT relies not only on the device itself but on how results are managed. Modern Point-of-care testing integrates with electronic health records (EHRs), laboratory information systems, and clinical decision support tools. Real-time data capture, remote monitoring and audit trails are essential for quality assurance, governance and population health analytics.

Applications across clinical settings

Point-of-care testing finds utility across a wide spectrum of clinical environments, from the GP practice to the ICU. Its relevance varies by setting, but the core principles—speed, accuracy, and actionable information—remain constant.

Primary care and general practice

In GP surgeries and community clinics, PoCT supports early diagnosis and rapid triage for infections, metabolic disturbances and cardiovascular risk. Point-of-care testing can guide decisions about prescribing antibiotics, initiating insulin therapy, or implementing lifestyle interventions. For chronic disease management, home PoCT devices for glucose, ketone, lipid or blood pressure monitoring can help patients and clinicians track control between visits.

Emergency and urgent care

In emergency departments and urgent care centres, Point-of-care testing accelerates decision making for chest pain, trauma, sepsis risk, and acute kidney injury. Point-of-care cardiac markers, lactate, and blood gas analysis are frequently used to stratify risk and prioritise treatment pathways, potentially shortening length of stay and improving throughput.

Inpatient and critical care

Within hospital wards and ICU settings, PoCT complements traditional laboratory testing by providing rapid results that influence dose adjustments, fluid management and organ support. Molecular PoCT can assist in infection control by rapidly identifying contagious pathogens, enabling timely isolation and targeted therapy.

Rural and remote healthcare

In remote or under-resourced regions, Point-of-care testing mitigates the challenges posed by distance to laboratories. Portable devices enable clinicians to assess risk, guide treatment and monitor chronic conditions without the need for patient transfer. This is particularly impactful in obstetrics, infectious disease management and post-acute care.

Home testing and patient self-management

Advances in consumer-friendly PoCT devices empower patients to monitor health indicators at home, supported by telehealth and clinician review. Home glucose monitoring, pregnancy tests and point-of-care coagulation tests are examples where patient engagement improves care continuity and adherence.

Quality, regulatory and safety considerations in Point-of-care testing

Ensuring accuracy, reliability and safety is essential for Point-of-care testing. The consequences of erroneous results can be significant, affecting patient outcomes and resource utilisation. A robust framework for quality assurance, device validation, competency and governance is central to successful PoCT implementation.

Quality control and quality assurance

PoCT programmes must implement ongoing quality control (QC) and external quality assessment (EQA). QC measures check that devices operate correctly on a daily basis, while EQA schemes calibrate performance against reference laboratories. Regular competency assessments for staff performing PoCT help maintain consistency and reliability across operators and sites.

Calibration, maintenance and traceability

Calibration protocols should be defined for each device, with scheduled maintenance and software updates. Traceability of samples and results—from device to patient record—ensures auditability and enables follow-up if discrepancies arise.

Regulatory frameworks in the UK and EU

PoCT devices fall under medical device regulations and, in the UK, are subject to MHRA oversight where applicable. Manufacturers are required to provide performance data, installation and maintenance guidance, and post-market surveillance. Healthcare organisations must implement governance structures to oversee PoCT use, including approach to risk management and incident reporting.

Clinical governance and workforce competencies

Staff training, governance policies, and clear accountability are essential. Clinicians must understand not only how to operate devices but also how to interpret results within the clinical context, recognising limitations and when to escalate to laboratory testing or specialist consultation.

Economic and implementation considerations

Adopting Point-of-care testing has financial and operational implications. A well-planned implementation considers upfront investment, running costs, and the broader impact on patient care pathways and hospital or clinic systems.

Cost-benefit and return on investment

While PoCT devices require initial expenditure, potential savings arise from reduced hospital admissions, shortened length of stay, and improved antibiotic stewardship. A formal cost-benefit analysis should account for device depreciation, consumables, maintenance, training and data integration requirements.

Workflow integration and IT systems

Successful PoCT integration demands alignment with existing workflows and electronic health records. Interfaces that automate result entry minimise duplicate data entry and the risk of transcription errors. Staff should have clear pathways for ordering, documenting, and acting on PoCT results within the patient record.

Data privacy, cybersecurity and interoperability

As PoCT devices become more connected, protecting patient privacy and securing data transmission is essential. Interoperability standards enable PoCT results to populate patient records consistently, supporting population health analytics and performance monitoring across networks.

Challenges and limitations of Point-of-care testing

Despite its many benefits, Point-of-care testing faces several challenges that organisations must manage to preserve quality and safety.

Analytical performance versus clinical utility

Some PoCT devices may trade off some analytical precision for speed and convenience. Clinicians should understand the limitations of each platform, including the potential for false positives or negatives and how that affects clinical decision making.

Operator variability and training needs

The accuracy of PoCT results is influenced by user technique, adherence to protocols and sample handling. Comprehensive training and ongoing competency assessment are essential to minimise operator-related errors.

Supply chain and device maintenance

Consumables and reagents for PoCT devices can be sensitive to storage conditions and expiry dates. A robust supply chain and inventory management system helps prevent interruptions in care and ensures test availability when needed.

Quality assurance in decentralised settings

Maintaining consistent quality across multiple sites, particularly in remote or mobile settings, requires well-defined governance, remote monitoring capabilities and periodic on-site audits.

Clinical governance and accountability

Clear delineation of responsibility for testing, interpreting results and acting on findings is critical. Governance frameworks should specify escalation pathways, clinician responsibility, and patient safety considerations.

Practical considerations for implementing Point-of-care testing

For healthcare organisations considering PoCT adoption, several practical steps help maximise benefit while maintaining safety and quality.

Needs assessment and setting the scope

Assess the clinical scenarios where PoCT can deliver the greatest value, considering patient flow, urgency, and potential impact on outcomes. Start with a targeted panel of tests that align with local patient needs and resource availability.

Device selection and validation

Choose devices with demonstrated performance in the intended setting. Conduct local validation studies to confirm accuracy, precision and robustness under routine conditions before full-scale deployment.

Training, competency and governance

Develop a comprehensive training programme covering device operation, result interpretation, quality control, infection control and data management. Establish a governance committee to oversee procurement, usage, and escalation protocols.

Clinical pathways and decision support

Integrate PoCT results into clinical pathways with clear thresholds and actions. Use decision-support tools to help clinicians interpret results in the context of patient presentation and comorbidities.

Monitoring, audit and continuous improvement

Set up performance dashboards to monitor test usage, accuracy, concordance with central laboratories and clinical outcomes. Regular audits support continuous improvement and accountability.

Future directions in Point-of-care testing

The field of Point-of-care testing is dynamic, driven by innovations in materials science, data science and personalised medicine. Several trends are poised to shape the next decade of PoCT development and application.

Multiplex and ultra-rapid testing

Future PoCT devices are likely to offer multiplex panels that assess multiple pathogens or biomarkers simultaneously from a single sample. This capability speeds diagnosis, supports antimicrobial stewardship and informs complex treatment decisions in a single encounter.

Smart connectivity and real-time analytics

Connectivity will enable PoCT devices to feed secure data streams into national health information systems, enabling population health monitoring, outbreak detection and improved resource planning. Real-time analytics will assist clinicians with risk stratification and management recommendations at the point of care.

Wearable and home-based PoCT

Wearable sensors and home-use devices will extend PoCT beyond clinical settings, enabling continuous monitoring of vital signs, metabolic markers and infectious disease indicators. Telemedicine platforms will integrate these data to support proactive care and early intervention.

personalised diagnostics and companion diagnostics

As understanding of individual biology grows, PoCT may be combined with companion diagnostic insights to tailor therapies precisely to the patient. Point-of-care platforms that deliver actionable pharmacodynamic information can support personalised medicine in real time.

Conclusion: The enduring value of Point-of-care testing

Point-of-care testing sits at the intersection of speed, accuracy and patient-centred care. By shortening the distance between testing and clinical action, Point-of-care testing transforms how clinicians diagnose, treat and monitor patients. With careful attention to quality assurance, workforce training, regulatory compliance and seamless data integration, PoCT can deliver meaningful improvements in patient outcomes, experience and health-system efficiency. As technology advances, testing at the point of care will become even more capable, enabling rapid decision making in a broader range of settings, from bustling urban centres to remote clinics and patients’ homes. The future of Point-of-care testing holds the promise of faster, smarter, more responsive healthcare for all.